Claims for Patent: 7,279,565

Summary for Patent: 7,279,565

Title:	Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
Abstract:	The exposure of cells, tissues and organs to \"stress,\" such as elevated temperature, stimulates production of active heat stress transcription factors (HSF), which in turn, induce expression of genes regulated by stress promoters. Normally, the activity of stress promoters declines after cells, tissues and organs are returned to a normal condition. The present invention relates to molecular circuits that provide for sustained expression of a gene of interest subsequent to a single application of stress. Generally, the molecular circuits of the invention comprise (a) a first nucleic acid molecule that comprises a gene encoding a transcription factor and a first promoter or a combination promoter activatable by stress and by the transcription factor, wherein the first promoter or the combination promoter and the transcription factor gene are operably linked, and (b) a second nucleic acid molecule that comprises a gene of interest and a second promoter activatable by the transcription factor, wherein the second promoter and the gene of interest are operably linked.
Inventor(s):	Voellmy; Richard (Pully, Vaud, CH)
Assignee:
Application Number:	10/996,420
Patent Claims:	1. A molecular circuit delivered into a cell, comprising (a) a first nucleic acid comprising a gene encoding a transcription factor, the gene being operably linked to a combination promoter activatable by stress and by the transcription factor, the combination promoter comprising a nucleotide sequence including a stress promoter and an associated RNA leader sequence into which a promoter activatable by the transcription factor is inserted or a nucleotide sequence including a promoter activatable by the transcription factor and an associated RNA leader into which a stress promoter is inserted, and (b) a second nucleic acid comprising a gene of interest, the gene of interest being operably linked to a promoter activatable by the transcription factor. 2. The molecular circuit of claim 1, wherein a single nucleic acid molecule comprises the first and second nucleic acids. 3. The molecular circuit of claim 1, wherein the promoter operably linked to the gene of interest is also a combination promoter activatable by stress and the transcription factor. 4. The molecular circuit of claim 3, wherein the gene encoding the transcription factor and the gene of interest are present on the same nucleic acid and are operably linked to a single combination promoter activatable by stress and the transcription factor. 5. The molecular circuit of claim 1, wherein the combination promoter comprises a nucleotide sequence including a stress promoter and an associated RNA leader sequence into which an intron sequence including a promoter activatable by the transcription factor is inserted or a nucleotide sequence including a promoter activatable by the transcription factor and an associated RNA leader into which an intron sequence including a stress promoter is inserted. 6. The molecular circuit of claim 5, wherein the combination promoter comprises a nucleotide sequence from the human Hsp70B stress gene including a stress promoter and an RNA leader sequence into which an intron sequence including a promoter activatable by the transcription factor is inserted. 7. The molecular circuit of claim 5, wherein the transcription factor is EcR/RXR or a transcription factor comprising a GAL4 DNA-binding domain and the combination promoter comprises a nucleotide sequence from the human Hsp70B stress gene including a stress promoter and an associated RNA leader sequence into which an intron sequence including a promoter activatable by the transcription factor is inserted. 8. A nucleic acid comprising a gene encoding a transcription factor, the gene being operably linked to a combination promoter activatable by stress and by the transcription factor, the combination promoter comprising a nucleotide sequence including a stress promoter and an associated RNA leader sequence into which a promoter activatable by the transcription factor is inserted or a nucleotide sequence including a promoter activatable by the transcription factor and an associated RNA leader into which a stress promoter is inserted. 9. A nucleic acid according to claim 8, wherein the combination promoter comprises a nucleotide sequence including a stress promoter and an associated RNA leader sequence into which an intron sequence including a promoter activatable by the transcription factor is inserted or a nucleotide sequence including a promoter activatable by the transcription factor and an associated RNA leader into which an intron sequence including a stress promoter is inserted. 10. A nucleic acid according to claim 9, wherein the combination promoter comprises a nucleotide sequence from the human Hsp70B stress gene including a stress promoter and an RNA leader sequence into which an intron sequence including a promoter activatable by the transcription factor is inserted. 11. A molecular circuit constituted in a host cell, comprising (a) a nucleic acid delivered into the cell comprising a gene encoding a transcription factor, the gene being operably linked to a promoter or combination promoter activatable by stress and by the transcription factor, and (b) a gene of the host cell that is activatable by the transcription factor. 12. A molecular circuit constituted in a host cell, comprising (a) a nucleic acid delivered into the cell comprising a gene encoding a first transcription factor, the gene being operably linked to a promoter or combination promoter activatable by stress and by the first transcription factor, (b) a nucleic acid delivered into the cell comprising a gene for a second transcription factor, the gene being operably linked to a promoter activatable by the first transcription factor, and (c) a gene of the host cell that is activatable by the second transcription factor. 13. The molecular circuit of claim 12, wherein the genes for first and second transcription factors are present on a single nucleic acid. 14. A molecular circuit constituted in a host cell, comprising (a) a nucleic acid delivered into the cell comprising a gene encoding a first transcription factor, the gene being operably linked to a stress promoter, (b) a nucleic acid delivered into the cell comprising a gene for a second transcription factor, the gene being operably linked to a promoter or combination promoter activatable by the first and second transcription factors, and (c) a gene of the host cell that is activatable by the second transcription factor. 15. The molecular circuit of claim 14, wherein both transcription factor genes are present on a single nucleic acid. 16. The molecular circuit of claim 14, wherein the first and second transcription factors are identical.

Details for Patent 7,279,565

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2018-05-05
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2018-05-05
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2018-05-05